Red Nucleus Enterprises (Renovus Portfolio) Acquires Pyxa Solutions

The Riverside Company Invests in Pyxa Systems as Add-on to Red Nucleus

April 8, 2020

Software

The Riverside Company has invested in Pyxa Systems (also marketed as DirectusPro), an R&D compliance and label-management software provider, as an add-on to its Red Nucleus Enterprises platform. The acquisition expands Red Nucleus’s software capabilities for regulatory and compliance functions serving global pharmaceutical and life sciences customers.

The Riverside Company Acquires Red Nucleus from Renovus Capital Partners

March 24, 2020

Education

The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.

Red Nucleus Acquires COEUS

February 4, 2025

Healthcare Services

Red Nucleus, a global strategic partner to life sciences companies, has acquired COEUS, a market access consulting and communications firm. The deal augments Red Nucleus' market access capabilities—particularly payor outreach, HEOR, patient access, and commercialization support—strengthening services for pharmaceutical and biotech clients.

Red Nucleus Acquires Jupiter Life Science Consulting

September 12, 2022

Consulting

Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.

THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company

October 17, 2024

Healthcare Services

THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.

Red Nucleus / Riverside Acquire INVIVO Communications

September 30, 2020

Healthcare Services

Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.